PAIN-0-SOMA 500 TAB - Dr Precision

PAIN-0-SOMA 500 TAB is a higher-strength formulation of Carisoprodol, delivering 500 mg of this centrally acting muscle relaxant in each tablet. It is specifically designed for patients suffering from intense musculoskeletal pain, spasms, or injury-related discomfort. By modulating signals between the brain and spinal cord, it helps reduce the perception of pain and allows muscles to relax more effectively. This results in improved patient mobility, less discomfort during rehabilitation, and faster recovery times.

The medication is ideal for short-term use in acute orthopedic conditions such as back pain, neck stiffness, muscle sprains, or post-operative recovery. Its action begins approximately 30 minutes after oral intake and provides relief for up to six hours. Because of its powerful effect, PAIN-0-SOMA 500 TAB is typically prescribed in cases where standard doses (350 mg) are insufficient for adequate pain control.

Manufactured under the pharmaceutical excellence of Bluepill Express, PAIN-0-SOMA 500 TAB is produced in WHO-GMP and ISO-certified facilities with strict adherence to international regulatory guidelines. The formulation undergoes stringent in-process quality control, ensuring uniformity, stability, and bioavailability across every batch. With dedicated export capability, Bluepill Express supports clients in over 140 countries including the USA, UK, Europe, Africa, and the Middle East, offering full documentation support such as Certificate of Analysis, MSDS, and Dossiers.

The tablet is designed for optimal patient compliance, with a film-coated finish that eases swallowing and minimizes gastrointestinal discomfort. It is offered in a variety of packaging formats including blister strips and bottles to suit different market demands. The product is especially popular among hospitals, orthopedic centers, sports injury clinics, and physiotherapy units where muscle relaxants are routinely used for supportive therapy.

PAIN-0-SOMA 500 TAB should only be used under the supervision of a qualified healthcare professional. Due to its sedative properties and risk of dependence, it is generally recommended for short-term use not exceeding two to three weeks. It may cause drowsiness, dizziness, or blurred vision in some patients, and activities requiring full alertness should be avoided during treatment.